“Medicinal cannabis was associated with improvements in depression and anxiety symptoms, as well as health-related quality of life,” investigators concluded.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Authors reported, “For some demographic sub-groups, we find evidence of modest increases in employment or wages, particularly for … those working in the agriculture sector.”
Investigators concluded, “Cannabinoids have a role in treating chronic neuropathic pain.”
#1: Voters and lawmakers in three more states enacted laws in 2022 legalizing adult-use marijuana possession and regulating retail cannabis markets.
Sixty percent of the participants in the intervention group were “no longer classified as clinical insomniacs” at the conclusion of the trial.
Investigators summarized, “Due to its effectiveness and convenience, medical marijuana therapy may be helpful for patients suffering from migraines.”
Researchers said that their study was among the “largest and longest real-world analysis of the efficacy and safety” of medical cannabis products.
“No cardiovascular treatment-emergent adverse drug effects emerged” during patients’ treatment with liquid cannabis extracts.